Linda De Munck

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 75 publications

Tailoring radiotherapy in cT1-2N1 breast cancer to nodal response on primary chemotherapy (RAPCHEM: BOOG 2010-03): 10-year follow-up results of a Dutch, prospective, registry study.

Tailoring radiotherapy in cT1-2N1 breast cancer to nodal response on primary chemotherapy (RAPCHEM: BOOG 2010-03): 10-year follow-up results of a Dutch, prospective, registry study.

Journal: The Lancet. Oncology

Published: February 27, 2026

Characteristics, treatment and survival in de novo and metachronous metastatic breast cancer: a nationwide comparative analysis.

Characteristics, treatment and survival in de novo and metachronous metastatic breast cancer: a nationwide comparative analysis.

Journal: Breast cancer research and treatment

Published: February 13, 2026

Impact of screening on late-stage breast cancer in the Netherlands: a population-based cohort study (2007-2016).

Impact of screening on late-stage breast cancer in the Netherlands: a population-based cohort study (2007-2016).

Journal: Breast (Edinburgh, Scotland)

Published: September 24, 2025

Development and internal validation of mammography feature-based prognostic models for distant recurrence-free survival of invasive breast cancer in a screening cohort.

Development and internal validation of mammography feature-based prognostic models for distant recurrence-free survival of invasive breast cancer in a screening cohort.

Journal: NPJ breast cancer

Published: September 17, 2025

Breast cancer incidence, by stage at diagnosis, and mortality in 21 European countries in the era of mammography screening: an international population-based study.

Breast cancer incidence, by stage at diagnosis, and mortality in 21 European countries in the era of mammography screening: an international population-based study.

Journal: The Lancet regional health. Europe

Published: August 12, 2025

Validation of minimal risk of recurrence classification by the Breast Cancer Index in early stage breast cancer.

Validation of minimal risk of recurrence classification by the Breast Cancer Index in early stage breast cancer.

Journal: NPJ breast cancer

Published: July 03, 2025

Trends in local, regional and contralateral breast tumor recurrence within five years after diagnosis in the Netherlands: a population-based study including 121347 patients.

Trends in local, regional and contralateral breast tumor recurrence within five years after diagnosis in the Netherlands: a population-based study including 121347 patients.

Journal: Breast (Edinburgh, Scotland)

Published: July 01, 2025

Outcomes for ER-positive CHEK2 c.1100delC breast cancer patients compared with breast cancer patients without the variant.

Outcomes for ER-positive CHEK2 c.1100delC breast cancer patients compared with breast cancer patients without the variant.

Journal: Breast (Edinburgh, Scotland)

Published: June 26, 2025

Notification of locoregional breast cancer recurrence based on pathology reports: A nationwide validation study with the Netherlands Cancer Registry.

Notification of locoregional breast cancer recurrence based on pathology reports: A nationwide validation study with the Netherlands Cancer Registry.

Journal: Cancer epidemiology

Published: December 20, 2024

Adding Anti-HER2 Therapy to Neoadjuvant Endocrine Therapy Seems Effective in Hormone Receptor and HER2 Positive Breast Cancer Patients Unfit for Chemotherapy: A Nationwide Population-Based Cohort Study.

Adding Anti-HER2 Therapy to Neoadjuvant Endocrine Therapy Seems Effective in Hormone Receptor and HER2 Positive Breast Cancer Patients Unfit for Chemotherapy: A Nationwide Population-Based Cohort Study.

Journal: Cancers

Published: November 18, 2024

Identification of Early-Stage Breast Cancer with a Minimal Risk of Recurrence by the Breast Cancer Index.

Identification of Early-Stage Breast Cancer with a Minimal Risk of Recurrence by the Breast Cancer Index.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 15, 2024

The INFLUENCE 3.0 model: Updated predictions of locoregional recurrence and contralateral breast cancer, now also suitable for patients treated with neoadjuvant systemic therapy.

The INFLUENCE 3.0 model: Updated predictions of locoregional recurrence and contralateral breast cancer, now also suitable for patients treated with neoadjuvant systemic therapy.

Journal: Breast (Edinburgh, Scotland)

Published: July 18, 2024

Showing 1-12 of 75

Last Updated: 09/26/2026